Gilead, HIV: FDA accetta NDA per lenacapavir come PrEP. La decisione a giugno
Gilead si sta avvicinando all'approvazione FDA di
lenacapavir – il suo inibitore della capsula del virus dell'immunodeficienza
umana-1 (HIV-1), ... |
Italiano — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.